Диссертация (1139925), страница 24
Текст из файла (страница 24)
// Radiother. Oncol. –2007. – Vol. 83, № 1. – P. 3-10.112. Salomon, L. Outcome and complications of radical prostatectomy in patientswith PSA<10 ng/ml: comparison between the retropubic, perineal and laparoscopicapproach / L. Salomon, O. Levrel, A.G. Anastasiadis et al. // Prostate Cancer ProstaticDis. – 2002. – Vol.
5, № 4. – P. 285-290.113. Saranchuk, J.W. Achieving optimal outcomes after radical prostatectomy /J.W. Saranchuk, M.W. Kattan, E. Elkin et al. // J. Clin. Oncol. – 2005. – Vol. 23, № 18.– P. 4146-4151.114. Sato, K. Arterial chemoembolization using microencapsulated anticancer drugs/ K. Sato, T. Kato // Gan to Kagaku Ryoho. – 1990. – Vol. 17, № 6. – Р. 1105-1110.115. Schuessler, W.W. Laparoscopic radical prostatectomy: initial short-term experience / W.W. Schuessler, P.G.
Schulam, R.V. Сlayman / W.W. Schuessler, L.R. Kavoussi // Urology. – 1997. – Vol. 50, № 6. – P. 854-857.116. Sooriakumaran, P. A multinational, multi-institutional study comparingpositive surgical margin rates among 22393 open, laparoscopic, and robot-assistedradical prostatectomy patients / P. Sooriakumaran, A. Srivastava, S.F. Shariat et al. //Eur Urol. – 2014. – Vol. 66, № 3. – Р.
450-456.117. Stock, R.G. Penile erectile function after permanent radioactive seedimplantation for treatment of prostate cancer / R.G. Stock, J. Kao, N.N. Stone // J. Urol.– 2001. – Vol.165. – Р. 436-439.118. Taira, A.V. Natural history of clinically staged lowand intermediate-riskprostate cancer treated with monotherapeutic permanent interstitial brachytherapy /A.V. Taira, G.S. Merrick, R.W. Galbreath // Int.
J. Radiat Oncol Biol Phys. – 2010. –Vol. 76, № 2. – P. 349-354.179119. Taylor, K.J. Differing hepatic lesions caused by the same dose of ultrasound /K.J. Taylor, C.C. Connolly // J. Pathol. – 1969. – Vol. 98, № 4. – P. 291-293.120. Tewari, A. An operative and anatomic study to help in nerve sparing duringlaparoscopic and robotic radical prostatectomy / A. Tewari, J.O. Peabody, M. Fischer //Eur. Urol. – 2003. – Vol. 43, № 5.
– P. 444-454.121. Tewari, A. Long-term survival probability in men with clinically localizedprostate cancer treated either conservatively or with definitive treatment (radiotherapyor radical prostatectomy) / A. Tewari, J.D. Raman, P. Chang // Urology. – 2006.
– Vol.68, № 6. – P. 1268-1274.122. Tewari, A. Long-term survival in men with high grade prostate cancer: acomparisonbetweenconservativetreatment,radiationtherapyandradicalprostatectomy - a propensity scoring approach / A. Tewari, G. Divine, P. Chang et al. //J. Urol. – 2007. – Vol. 177, № 3. – P. 911-915.123.
Tewari, A. Technique of da Vinci robot-assisted anatomic radicalprostatectomy / A. Tewari, J. Peabody, R. Sarle et al. // Urology. – 2002. – Vol. 60, №4. – P. 569-572.124. Thuroff, S. High intensity focused ultrasound and localized prostate cancer:efficacy results from the European multi centric study / S. Thuroff, C. Chaussy, G.Vallancien et al. // J. Endourol. – 2003. – Vol. 17, № 8. – P.
673-677.125. Uchida, T. Transrectal highintensity focused ultrasound for treatment ofpatients with stage T1b-2N0M0 localized prostate cancer: a preliminary report / T.Uchida, N.T. Sanghvi, T.A. Gardner et al. // Urology. – 2002. – Vol. 59, № 3. – P. 394398.126. Uchida, Т. Five years experience of transrectal high-intensity focusedultrasound using the Sonablate device in the treatment of localized prostate cancer / Т.Uchida, H. Ohkusa, H. Yamashita et al. // Int. J. Urol. – 2006. – Vol. 13, № 3. – P. 228233.127.
Uchida, Т. Treatment of localized prostate cancer using high-intensity focusedultrasound / Т. Uchida, H. Ohkusa, Y. Nagata et al. // BJU Int. – 2006. – Vol. 97. – № 1.– P. 56-61.180128. Vaezy, S. Use of highintensity focused ultrasound to control bleeding / S.Vaezy, R. Martin, P. Kaczkowska et al. // J. Vasc. Surg. – 1999.
– Vol. 29, № 3. – P.533-542.129. Vaughan, M. Minimally invasive cancer surgery using focused ultrasound: apre - clinical, normal tissue study / M. Vaughan, G. Haa, C.R. Hill et al. // Br. J. Radiol.– 1994. – Vol. 67, № 795. – P. 267-274.130. Vogl, T.J. Percutaneous Tumor Ablation in Medical Radiology / T.J.
Vogl,T.K. Helmberger, M.G. Mack. – 2008, Springer-Verlag, Berlin; Heidelberg, New York.– 258 р.131. Walsh, P.C. Cancer control and quality of life following anatomical radicalretropubic prostatectomy: results at 10 years / P.C. Walsh, A.W. Partin, J.I. Epstein // J.Urol. – 1994. – Vol.152. – Р. 1831-1836.132. Walsh, P.C. Impotence following radical prostatectomy: insight into etiologyand prevention / P.C. Walsh, P.J. Donker // J. Urol. – 1982.
– Vol. 128, № 3. – P. 492497.133. Warwick, R. Trackless lesions in nervous tissues produced by high intensityfocused ultrasound (high intensity mechanical waves) / R. Warwick, J. Pond // J. Anat.– 1968. – Vol. 102, № 3. – P. 387-405.134. Whaley, J.T. Sexual function and the use of medical devices or drugs tooptimize potency after prostate brachytherapy / J.T. Whaley, L.B. Levy, D.A. Swansonet al. // Int.
J. Radiat. Oncol. Biol. Phys. – 2012. – Vol.82, № 5. – Р.765-71.135. Wu, F. Circulating tumor cells in patients with solid malignancy treated byhighintensive focused ultrasound / F. Wu, Z.B. Wang, C.B. Jin et al. // Ultrasound Med.Biol. – 2004. – Vol. 30, № 4. – P. 511-517.136. Wu, F. Extracorporeal high intensity focused ultrasound ablation in thetreatment of 1038 patients with solid carcinomas in China: an overview / F.
Wu, Z.B.Wang, W.Z. Chen et al. // Ultrason. Sonochem. – 2004. – Vol. 11, № 3-4. – P. 149-154.137. Wu, F. Extracorporeal high intensity focused ultrasound ablation in thetreatment of patients with large hepatocellular carcinoma / F. Wu, Z.B. Wang, W.Z.Chen et al. // Ann. Surg. Oncol. – 2004. – Vol. 11, № 12. – P. 1061-1069.181138. Wu, F. Feasibility of US guided highintensity focused ultrasound treatment inpatients with advanced pancreatic cancer: initial experience / F. Wu, Z.B.
Wang, H. Zhuet al. // Radiology. – 2005. – Vol. 236, № 3. – P. 1034-1040.139. Wu, F. Non-invasive ablation of high intensity focused ultrasound for thetreatment of patients with malignant bone tumors / F. Wu, Z.B. Wang, W.Z. Chen et al.// J. Bone Joint Surg. – 2005. – Vol. 87. – Р.4.140. Wu, F. Pathological changes in human malignant carcinoma treated withhighintensity focused ultrasound / F. Wu, W.Z. Chen, J. Bai et al. // Ultrasound Med.Biol. – 2001. – Vol. 27, № 8. – P. 1099-2006.141.
Wu, F. Preliminary experience using high intensity focused ultrasound for thetreatment of patients with advanced stage renal malignancy / F. Wu, Z.B. Wang, W.Z.Chen et al. // J. Urol. 2003. – Vol. 170, № 6. – P. 2237-2240.142. Wu, F. Tumor vessel destruction resulting from highintensity focusedultrasound in patients with solid malignancies / F. Wu, W.Z. Chen, J. Bai et al.
//Ultrasound Med. Biol. – 2002. – Vol. 28, № 4. – P. 535-542.143. Wymenga, L.F.A. Ultrasound-guided seminal vesicle biopsies in prostatecancer / L.F.A. Wymenga, F.J. Duisterwinkel, K. Groenier et al. // Prostate. CancerProstatic Dis. – 2000. – Vol. 3, № 2. – P. 100-106.144. Yu, L. Comparison of uterine artery chemoembolization and internal iliacarterial infusion chemotherapy for the combining treatment for women with locallyadvanced cervical cancer / L.
Yu, G.S. Tan, X.H. Xiang et al. // Ai Zheng. – 2009. –Vol.28, № 4. – Р. 402-407..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
